Skip to main content
SpringerLink
Log in

Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Aim

To investigate the therapeutical effect of vitamin D supplementation on the metabolism and endocrine parameters of PCOS patients.

Materials and methods

Clinical studies investigating the therapeutic effect of vitamin D supplementation on PCOS patients were selected by searching PubMed, Embase, The Cochrane library and Web of Science until April 2016. The included articles were selected according to the inclusion criteria. Serum HOMA-IR, QUICKI, LDL, DHEAS, free testosterone (FT), total testosterone (TT), PTH, 25-hydroxy-vitamin D, and triglyceride of PCOS patients were enrolled for evaluating the therapeutic effects of vitamin D.

Results

16 studies were included in this study. There was no significant difference between the placebo group and vitamin D group in the concentration of serum 25-hydroxy-vitamin D in patients with PCOS (P = 0.06). After treated with vitamin D, the serum 25-hydroxy-vitamin D in PCOS patients was increased (P < 0.00001), while the serum PTH (P = 0.003) and triglyceride (P = 0.006) were decreased. In addition, the serum HOMA-IR, QUICKI, LDL, DHEAS, FT, and TT in PCOS patients did not change. Subgroup analysis showed that the serum triglyceride of PCOS patients was decreased by low dose of vitamin D supplementation (<50,000 IU) (P = 0.03), but no significantly changed by high-dose vitamin D supplementation (≥50,000 IU) (P = 0.17).

Conclusion

Vitamin D supplementation significantly attenuates serum PTH and triglyceride in PCOS patients except for serum HOMA-IR, QUICKI, LDL, DHEAS, FT, and TT. Furthermore, less than 50,000 IU vitamin D supplementation is sufficient for decreasing serum triglyceride.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Baskind NE, Balen AH (2016) Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 37:80–97

    Article  PubMed  Google Scholar 

  2. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930

    Article  CAS  PubMed  Google Scholar 

  3. Patra SK, Nasrat H, Goswami B, Jain A (2012) Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 6:146–149

    Article  PubMed  Google Scholar 

  4. Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, Mezza T, Vieth R, Colao A, Pittas A (2014) Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol 171:R101–R110

    Article  CAS  PubMed  Google Scholar 

  5. Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J, Taylor H (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28:965–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92:191–206

    Article  CAS  PubMed  Google Scholar 

  7. Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L, MohammadTaheri S (2012) Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract 18:85–88

    Article  PubMed  Google Scholar 

  8. Wehr E, Pieber TR, Obermayer-Pietsch B (2011) Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 34:757–763

    CAS  PubMed  Google Scholar 

  9. Garg G, Kachhawa G, Ramot R, Khadgawat R, Tandon N, Sreenivas V, Kriplani A, Gupta N (2015) Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocr Connect 4:108–116

    Article  PubMed  PubMed Central  Google Scholar 

  10. Raja-Khan N, Shah J, Stetter CM, Lott ME, Kunselman AR, Dodson WC, Legro RS (2014) High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized controlled pilot trial. Fertil Steril 101:1740–1746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. He C, Lin Z, Robb SW, Ezeamama AE (2015) Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients 7:4555–4577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Thomson RL, Spedding S, Buckley JD (2012) Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 77:343–350

    Article  CAS  Google Scholar 

  13. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, Obermayer-Pietsch B (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 161:575–582

    Article  CAS  PubMed  Google Scholar 

  14. Kyrkou G, Trakakis E, Attilakos A, Panagopoulos P, Chrelias C, Papadimitriou A, Vaggopoulos V, Alexiou E, Mastorakos G, Lykeridou A, Kassanos D, Papaevangelou V, Papantoniou N (2016) Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study. Arch Gynecol Obstet 293:915–923

    Article  CAS  PubMed  Google Scholar 

  15. Razavi M, Jamilian M, Karamali M, Bahmani F, Aghadavod E, Asemi Z (2016) The effects of vitamin D-K–calcium co-supplementation on endocrine, inflammation, and oxidative stress biomarkers in vitamin D-deficient women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Horm Metab Res 48:446–451

    Article  CAS  PubMed  Google Scholar 

  16. Tao MF, Zhang Z, Ke YH, He JW, Fu WZ, Zhang CQ, Zhang ZL (2013) Association of serum 25-hydroxyvitamin D with insulin resistance and beta-cell function in a healthy Chinese female population. Acta Pharmacol Sin 34:1070–1074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Jia XZ, Wang YM, Zhang N, Guo LN, Zhen XL, Li H, Wei L (2015) Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis. J Obstet Gynaecol Res 41:1791–1802

    Article  CAS  PubMed  Google Scholar 

  18. Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A (2015) Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 34:586–592

    Article  CAS  PubMed  Google Scholar 

  19. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47

    Article  Google Scholar 

  20. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92:1053–1058

    Article  CAS  PubMed  Google Scholar 

  21. Ardabili HR, Gargari BP, Farzadi L (2012) Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 32:195–201

    Article  CAS  PubMed  Google Scholar 

  22. Irani M, Seifer DB, Grazi RV, Julka N, Bhatt D, Kalgi B, Irani S, Tal O, Lambert-Messerlian G, Tal R (2015) Vitamin D supplementation decreases TGF-beta1 bioavailability in PCOS: a randomized placebo-controlled trial. J Clin Endocrinol Metab 100:4307–4314

    Article  CAS  PubMed  Google Scholar 

  23. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S (2010) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33:234–238

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study is financially supported by the National Natural Science Foundation of China (Grant No. 81401176).

Author information

Author notes

    Authors and Affiliations

    1. Department of Gynecology, Nanjing Maternity and Child Health Care Hospital, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, 123 Mochou Road, 210004, Nanjing, Jiangsu Province, China

      Yunping Xue, Kai Xue, Xiaoyi Duan, Jian Cao, Ting Luan, Qian Li & Lin Gu

    2. Department of Health Medical Institute, Nanjing Maternity and Child Health Care Hospital, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, 210004, Nanjing, China

      Pengfei Xu

    Authors
    1. Yunping Xue
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Pengfei Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Kai Xue
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Xiaoyi Duan
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Jian Cao
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ting Luan
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Qian Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Lin Gu
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Qian Li or Lin Gu.

    Ethics declarations

    Conflict of interest

    The authors have declared no conflict of interest.

    Ethical approval

    This article does not contain any studies with human participants or animals performed by any of the authors.

    Additional information

    Y. Xue and P. Xu contributed equally.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Xue, Y., Xu, P., Xue, K. et al. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis. Arch Gynecol Obstet 295, 487–496 (2017). https://doi.org/10.1007/s00404-016-4247-y

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00404-016-4247-y

    Keywords

    Search

    Navigation